Siemens POC HS cTn-I
Showing 26 - 50 of >10,000
based Approaches for Improving Diagnosis of Childhood
Recruiting
- Tuberculous Meningitis
-
Cape Town, Western Cape, South AfricaStellenbosch University Immunology Research Group
May 16, 2022
Advanced Solid Tumor Trial in Shanghai (HS-10386)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Jun 20, 2023
Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)
Completed
- Neoplasm
- Solid Tumors
-
Camperdown, New South Wales, Australia
- +1 more
Jul 18, 2022
Hemorrhage, Laceration Trial in Saint Louis (Audio kit, Instructional flashcard, In-person training)
Recruiting
- Hemorrhage
- Laceration
- Audio kit
- +2 more
-
Saint Louis, MissouriWashington University in St. Louis - McKelvey School of Engineer
Apr 11, 2023
Trigeminal Neuralgia Trial in Hangzhou (EA+ Carbamazepine, EA+Placebo, sham EA+Carbamazepine)
Completed
- Trigeminal Neuralgia
- EA+ Carbamazepine
- +3 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Sep 13, 2022
Bladder Tumor, Magnetic Resonance Imaging Trial in Guangzhou (MRI)
Recruiting
- Bladder Tumor
- Magnetic Resonance Imaging
- MRI
-
Guangzhou, Guang Dong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 4, 2023
Post-COVID-19 Syndrome Trial (Exercise Therapy, Psychotherapy)
Not yet recruiting
- Post-COVID-19 Syndrome
- Exercise Therapy
- Psychotherapy
- (no location specified)
Sep 12, 2023
Hidradenitis Suppurativa, Acne Inversa Trial (Nd:YAG laser hair removal, Clindamycin 1 % Topical Lotion)
Not yet recruiting
- Hidradenitis Suppurativa, Acne Inversa
- Nd:YAG laser hair removal
- Clindamycin 1 % Topical Lotion
- (no location specified)
Feb 28, 2023
Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)
Recruiting
- Nonsmall Cell Lung Cancer
- HS-10365 capsules
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 22, 2023
Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)
Not yet recruiting
- Psoriasis
- HS-10374 tablets 1mg
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital of Fudan University
Oct 8, 2023
HIDRAdenitis Suppurativa and HEART Disease
Enrolling by invitation
- Hidradenitis
- +10 more
-
Hellerup, Copenhagen, DenmarkDepartment of Cardiology, Herlev and Gentofte University Hospita
Aug 4, 2023
Multicenter Registry on Robotically Assisted PCI - TESLA
Recruiting
- Coronary Artery Disease
- Robotically-Assisted Percutaneous Coronary Intervention with CorPath GRX System
-
Nowy Sacz, Malopolska, PolandCentrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii
Apr 24, 2023
Hidradenitis Suppurativa Trial in Minneapolis (Fecal Microbiota - lyophilized, Placebo drug)
Not yet recruiting
- Hidradenitis Suppurativa
- Fecal Microbiota - lyophilized
- Placebo drug
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 2, 2023
Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)
Not yet recruiting
- Metastasis Castration Resistant Prostate Cancer(mCRPC)
- (no location specified)
Aug 14, 2023
NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- HS-10241+ Almonertinib
- Pemetrexed + Cisplatin /Carboplatin
- (no location specified)
Oct 29, 2023
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
Completed
- COVID-19 Respiratory Infection
-
Geneva, Switzerland
- +2 more
Sep 25, 2023
Patients With Opioid Use Disorder
Completed
- Opioid-use Disorder
- Clinical program implementation
-
Manchester, New Hampshire
- +1 more
Jan 27, 2023
Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Combined risk score, Usual care, point-of-care
Not yet recruiting
- Acute Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- Combined risk score
- +2 more
- (no location specified)
Sep 18, 2023
Next Generation LAM Assays and Molecular Diagnostics for
Not yet recruiting
- Tuberculosis
- (no location specified)
Aug 24, 2023